Advisory Services Network, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Advisory Services Network, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.0 - $1.53 $242 - $370	242 New	242 $0
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $435 - $619	242 New	242 $0
Q3 2021 Nov 05, 2021	SELL	$3.38 - $5.35 $817 - $1,294	-242 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$4.12 - $5.87 $997 - $1,420	242 New	242 $1,000
Q1 2021 May 24, 2021	SELL	$3.45 - $9.09 $834 - $2,199	-242 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.44 - $2.1 $348 - $508	242 New	242 $0
Q2 2020 Aug 10, 2020	SELL	$1.75 - $2.3 $423 - $556	-242 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$3.16 - $5.15 $316 - $515	100 Added 70.42%	242 $1,000
Q2 2017 Aug 17, 2017	BUY	N/A	142	142 $2,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.